On 2026-08-05, Odyssey Therapeutics, Inc. (ODTX) announced earnings per share of $-1.26 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-0.83.

The next expected annoucement date for quarterly earnings is 2026-11-04, with an average estimated earnings per share of $-1.14 for the fiscal quarter ending 2026-09-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.